Home » Clinical Trials » Solid tumors » NCT05341492
NCT05341492

A Single-arm, Open, Exploratory Clinical Study Evaluating the Safety and Efficacy of EGFR/B7H3 CAR-T in Patients With EGFR/ B7H3-positive Advanced Solid Tumors (Lung and Triple-negative Breast Cancer)

Study Summary

This study is a single-arm, open, exploratory clinical study to evaluate the safety and efficacy of EGFR/B7H3 CAR-T in patients with EGFR/ B7H3-positive advanced solid tumors (lung cancer and triple-negative breast cancer)

Want to learn more about this trial?

Request More Info

Interventions

EGFR/B7H3 CAR-TBIOLOGICAL
2 × 10\^6/kg CAR-T cells,For subjects with body weight greater than 60 kg, the number of cells can only be calculated according to 60 kg of body weight.

Study Locations

FacilityCityStateCountry
Second Affiliated Hospital of Guangzhou Medical UniversityGuangzhouGuangdongChina

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026